Back to investors
PATIENT SQUARE CAPITAL LP
PATIENT SQUARE CAPITAL LP
Latest filing: 2026-06-30
PATIENT SQUARE CAPITAL LP runs PATIENT SQUARE CAPITAL LP and currently holds 23 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $645.52M. Their top holdings are ROIV, RVMD, MIRM, ABVX, ONC. The top five represent 64.9% of reported portfolio weight. PATIENT SQUARE CAPITAL LP ranks #159 out of 1000 investors tracked by Alpha Score. In the most recent quarter, PATIENT SQUARE CAPITAL LP initiated 4 new positions. They added to 8 existing positions. They trimmed 7 positions. Their current best-performing preview position is RCUS with returns of +42.73%.
Sign in to enable email alerts for this investor.
Showper page
23 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 ROIV ROIVANT SCIENCES LTD | 43.97% | $9.01 | $36.30 | +302.89% | Trimmed -1.78% |
 RVMD REVOLUTION MEDICINES INC | 8.01% | $187.28 | $209.46 | +11.84% | New Buy |
 MIRM MIRUM PHARMACEUTICALS INC | 4.72% | $72.35 | $96.31 | +33.12% | Added +13.26% |
 ABVX ABIVAX SA | 4.26% | $104.87 | $114.95 | +9.61% | Added +70.32% |
 ONC BEONE MEDICINES LTD | 3.97% | $300.97 | $374.47 | +24.42% | Added +11.77% |
 PHVS PHARVARIS N V | 3.60% | $25.98 | $36.27 | +39.61% | Added +36.15% |
 ARGX ARGENX SE | 3.31% | $686.33 | $1,039.78 | +51.50% | Trimmed -37.36% |
 UTHR UNITED THERAPEUTICS CORP DEL | 3.12% | $541.83 | $513.12 | -5.30% | New Buy |
 COGT COGENT BIOSCIENCES INC | 2.55% | $36.91 | $36.73 | -0.49% | Trimmed -28.69% |
 XENE XENON PHARMACEUTICALS INC | 2.06% | $50.13 | $60.77 | +21.22% | Trimmed -3.08% |
Showing 1-10 of 23